Search
+
    SEARCHED FOR:

    TARGET SEGMENTATION

    HEG Advanced Materials shares gain 5% after subsidiary secures Rs 610 crore incentive under ECMS

    HEG Advanced Materials shares rise 5% after subsidiary TACC receives ₹609.50 crore incentive approval under the ECMS scheme for its Dewas synthetic graphite anode project, supporting domestic battery manufacturing, capacity expansion and India's advanced energy storage ecosystem. The first production phase targets commissioning by June 2027.

    Titan bets on studded jewellery, premium watches and eyewear to drive growth

    Titan’s strong Q2 performance, driven by studded jewellery and premiumisation, is expected to sustain earnings growth, with gold price stability and a prolonged wedding season likely to revive buyer growth.

    Government extends ₹2,700-crore PLI scheme for medical devices till 2035-36, eases eligibility norms

    The government has extended the ₹2,700-crore production-linked incentive (PLI) scheme for domestic medical device manufacturing until 2035-36 and invited fresh applications with relaxed eligibility and investment conditions. The revised rules remove the minimum sales threshold for claiming incentives and lower the minimum investment requirement to attract more manufacturers.

    India well on track to achieve $1 trillion exports target for FY27: Piyush Goyal

    Commerce Minister Piyush Goyal said India is on track to achieve its $1 trillion goods and services export target in FY27, having already recorded nearly $480 billion in exports during April-September. He highlighted opportunities from free trade agreements, particularly the proposed India-EU pact, for the automobile and mobility sectors. Goyal urged manufacturers to expand globally, boost competitiveness and leverage international partnerships to drive exports, investment and employment.

    Government invites fresh applications under Rs 2,700 crore medical device PLI scheme

    The government is inviting new applications under the Production Linked Incentive Scheme for Medical Devices. This scheme has been extended until 2035-36 with an outlay of Rs 2,700 crore. Eligibility conditions have been simplified, and new applicants can submit multiple applications across different target segments. The revised scheme aims to enhance domestic manufacturing of high-end medical devices and improve global competitiveness.

    These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%

    The FPIs that were selling in the Indian market all these months mostly owned large-cap stocks. And as they sold them, it was that segment which bore the brunt of the selling. The same logic will operate in reverse as they start buying, focusing once again on the safer and more liquid large-cap stocks.

    The Economic Times
    BACK TO TOP
    Advertisement